A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies
about
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic miceQuantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.Matching chelators to radiometals for radiopharmaceuticals.Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL.Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.Positive progress in immunoPET--not just a coincidence.Diagnostic PET Imaging of Mammary Microcalcifications Using 64Cu-DOTA-Alendronate in a Rat Model of Breast Cancer.Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis.MEDICINAL RADIOPHARMACEUTICAL CHEMISTRY OF METAL RADIOPHARMACEUTICALS
P2860
Q33854382-027C7924-7B51-4C51-A196-6765EA1C1F76Q33926907-A57AB19F-A379-4572-9701-3EDFA5ADDDCBQ34196254-BFCB4686-F753-438B-AD5F-3CC420C3C5D2Q34328761-264AAA1A-302F-4843-9302-BE8A63F0650AQ35002038-DB2C6750-6644-4097-9EE7-1908162684D8Q35636908-870AEF40-8568-4978-829A-34A761627C8EQ36096813-003C4A46-5E30-45D9-A5DB-38F15027F639Q37172093-966B6CCF-7711-478B-A7D9-2B768837678BQ37207310-AF9C00C5-A7B8-4200-B3CF-76CC50763E4AQ37850696-6B18F666-3002-4A2B-A573-D651D3EC4AB2Q37869905-88B10A6E-7F90-46D7-8634-58BAE0C6CA13Q38156660-E45E9A7D-0FAF-4DFE-8411-A617E39D2A67Q39414818-78625E5A-CA5F-4BD4-BCBB-0C7FD6E5E087Q39608420-3FBBAEFC-2C2C-4D63-855C-5D63983E6AACQ42429164-B840E9A1-85E8-4D6C-A3C9-6DD83C344862Q46365253-D7592C40-92A9-43BE-992D-39A8D138297FQ47114491-44F36A06-F570-4753-8284-010ED44B83C9Q56619661-638FCAE5-92ED-4CDB-8CC8-734E20971AED
P2860
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A versatile bifunctional chela ...... e tumors with whole antibodies
@en
type
label
A versatile bifunctional chela ...... e tumors with whole antibodies
@en
prefLabel
A versatile bifunctional chela ...... e tumors with whole antibodies
@en
P2093
P2860
P356
P1476
A versatile bifunctional chela ...... e tumors with whole antibodies
@en
P2093
Amitkumar H Ahuja
Andrew Raubitschek
David Colcher
Desiree Crow
James Bading
Jeffrey Y C Wong
John E Shively
Lawrence E Williams
Paul J Yazaki
P2860
P356
10.1021/BC700161P
P577
2007-11-08T00:00:00Z